Get startedLog in
    Picture of SCHOTT Pharma AG & Co. KGaA logo

    1SXP — SCHOTT Pharma AG & Co. KGaA News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: SCHOTT Pharma Says Q1 Revenue EUR 240.2 Million

    Picture of SCHOTT Pharma AG & Co. KGaA logoSCHOTT Pharma AG & Co. KGaA
    11/02/2026 06:04
    Feb 11 (Reuters) - SCHOTT PHARMA AG & CO KGAA 1SXP.DE:

SCHOTT PHARMA WITH POSITIVE START TO FINANCIAL YEAR 2026; OUTLOOK CONFIRMED

Q1 2026 REVENUE UP 4.8% TO EUR 240.2 MILLION

Q1 2026 EBITDA MARGIN AT 27.1%

CONFIRMS 2026 FINANCIAL YEAR OUTLOOK

Q1 2026 CASH FLOW DOWN TO EUR 3.4 MILLION

Q1 2026 CAPEX AT EUR 23.4 MILLION

Q1 EBITDA AMOUNTED TO EUR 65.2 MILLION

Source text: ID:nEQ8fn6sZa

Further company coverage: 1SXP.DE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com ; +48 587785269;;))

    Recent news on SCHOTT Pharma AG & Co. KGaA

    See all news